Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricEWEdwards LifesciencesBSXBoston ScientificIDXXIdexx Laboratories
Snapshot
Price$90.03$49.92$596.54
Market cap$54.34B$67.09B$44.00B
Valuation
P/E47.2x20.8x43x
Forward P/E67.5x14.8x34.2x
Growth
Revenue growth13.8%17.4%13.1%
EPS growth-73.2%74.7%25.6%
Profitability
Net margin17.4%17.3%24.6%
ROE10.6%14.9%70.9%
Balance sheet & cash
Debt / equity0.06x0.47x0.53x
Free cash flow yield2.9%3.5%1.9%
Dividend yield———
Verdict
Investment ratingNeutral· 47Favorable· 71Favorable· 65

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearEWtoday $90BSXtoday $50IDXXtoday $597
2027$68.87 – $101.01+12% CAGR$65.42 – $95.94+92% CAGR$561.90 – $824.11+38% CAGR
2028$70.25 – $103.03+7% CAGR$114.29 – $167.63+83% CAGR$705.69 – $1,035.00+32% CAGR
2029$71.66 – $105.09+5% CAGR$199.69 – $292.88+80% CAGR$886.27 – $1,299.86+30% CAGR
2030$73.09 – $107.20+4% CAGR$348.90 – $511.73+79% CAGR$1,113.07 – $1,632.50+29% CAGR
2031$74.55 – $109.34+4% CAGR$609.61 – $894.09+78% CAGR$1,397.90 – $2,050.25+28% CAGR
5-yr CAGR-3.7% – 4.0%65.0% – 78.1%18.6% – 28.0%